Cephalon Inc. et al v. Watson Pharmaceuticals Inc. et al
Cephalon Inc. and CIMA Labs Inc. |
Watson Pharmaceuticals Inc. and Watson Laboratories Inc. |
1:2008cv00330 |
June 2, 2008 |
US District Court for the District of Delaware |
Patent Office |
XX US, Outside State |
Unassigned Judge |
None |
Federal Question |
35:271 Patent Infringement |
Available Case Documents
The following documents for this case are available for you to view or download:
Document Text |
---|
Filing 327 OPINION. Signed by Judge Sue L. Robinson on 3/11/11. (fms) |
Filing 290 MEMORANDUM ORDER, having been apprised that the 30-month stay in this Hatch-Waxman case has now lapsed; IT IS ORDERED that defendants are hereby enjoined from launching a generic version of Cephalons Fentora brand fentanyl citrate buccal tablets, not withstanding the impending grant of final approval on ANDA 79-075 by the FDA, until the court issues its opinion in the above-captioned matter. Signed by Judge Sue L. Robinson on 10/28/2010. Associated Cases: 1:08-cv-00330-SLR, 1:09-cv-00724-SLR(nmf) |
Filing 128 (SEALED) MEMORANDUM OPINION. Signed by Judge Sue L. Robinson on 4/3/2009. (nmf) (Additional attachment(s) added on 4/6/2009: # 1 Main Document) (lid). Modified on 4/6/2009 (lid). |
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.